Risk for Premature Mortality and Intentional Self-harm in Autism Spectrum Disorders.


Journal

Journal of autism and developmental disorders
ISSN: 1573-3432
Titre abrégé: J Autism Dev Disord
Pays: United States
ID NLM: 7904301

Informations de publication

Date de publication:
Sep 2021
Historique:
accepted: 22 10 2020
pubmed: 4 11 2020
medline: 20 8 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

To examine the risk for premature mortality and intentional self-harm in autism spectrum disorders (ASD). Based on a national birth cohort. Children born in 1987-2005, diagnosed with ASD by 2007 (n = 4695) were matched with four non-ASD subjects (n = 18,450) and followed until 2015 for mortality and intentional self-harm. The risk among ASD subjects was elevated only for natural cause of death. The risk for intentional self-harm was increased in the unadjusted analyses, but decreased to non-significant after adjusting for comorbid psychiatric disorders. ASD subjects are at increased risk for premature mortality due to natural causes of death. While ASD subjects die of suicide and present with more self-harm, the association is explained by comorbid psychiatric disorders.

Identifiants

pubmed: 33140146
doi: 10.1007/s10803-020-04768-x
pii: 10.1007/s10803-020-04768-x
pmc: PMC8349316
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3098-3108

Subventions

Organisme : American Foundation for Suicide Prevention
ID : DIG-1-139-15
Organisme : Academy of Finland Flagship Programme
ID : decision number: 320162
Organisme : Strategic Research Council at the Academy of Finland
ID : decision number: 303581
Organisme : Academy of Finland Health from Cohorts and Biobanks Programme
ID : decision number: 308552
Organisme : Brain and Behavior Research Foundation
ID : -
Organisme : Academy of Finland
ID : -
Organisme : Finnish Medical Foundation
ID : -
Organisme : Brain and Behavior Research Foundation
Organisme : Academy of Finland
Organisme : Finnish Medical Foundation

Informations de copyright

© 2020. The Author(s).

Références

Lancet Psychiatry. 2014 Jun;1(1):73-85
pubmed: 26360404
Acta Paediatr. 2014 Sep;103(9):984-90
pubmed: 24862980
J Am Acad Child Adolesc Psychiatry. 2018 May;57(5):313-320.e6
pubmed: 29706160
Lancet. 2016 Mar 19;387(10024):1227-39
pubmed: 26385066
J Clin Psychiatry. 2017 Nov/Dec;78(9):e1174-e1179
pubmed: 28872268
J Autism Dev Disord. 2011 Aug;41(8):1090-6
pubmed: 21082229
Biol Psychiatry. 2008 Oct 1;64(7):577-82
pubmed: 18565495
Br J Psychiatry. 2016 Mar;208(3):232-8
pubmed: 26541693
Psychiatry Res. 2013 May 30;207(3):203-11
pubmed: 23391634
Autism Res. 2014 Aug;7(4):507-21
pubmed: 24798640
Child Psychiatry Hum Dev. 2016 Aug;47(4):574-82
pubmed: 26399420
J Autism Dev Disord. 2002 Jun;32(3):217-24
pubmed: 12108623
Lancet Psychiatry. 2014 Jul;1(2):142-7
pubmed: 26360578
J Autism Dev Disord. 2010 Mar;40(3):352-7
pubmed: 19838782
JAMA Pediatr. 2016 Mar;170(3):243-50
pubmed: 26752506
Autism. 2008 Jul;12(4):403-14
pubmed: 18579647
J Autism Dev Disord. 2014 Oct;44(10):2547-57
pubmed: 24803367
Forensic Sci Int. 2001 Jan 1;115(1-2):15-32
pubmed: 11056267
J Autism Dev Disord. 2001 Dec;31(6):569-76
pubmed: 11814268
Acta Paediatr. 2010 Sep;99(9):1425-8
pubmed: 20412100
J Autism Dev Disord. 2006 Oct;36(7):849-61
pubmed: 16845581
Dev Med Child Neurol. 2012 Apr;54(4):306-12
pubmed: 22348343
J Autism Dev Disord. 2006 Feb;36(2):287-8
pubmed: 16565885
Clin Pract Epidemiol Ment Health. 2011 Mar 30;7:97-105
pubmed: 21566670
J Autism Dev Disord. 2013 May;43(5):1196-204
pubmed: 23008058

Auteurs

Elina Jokiranta-Olkoniemi (E)

Department of Child Psychiatry, University of Turku and Turku University Hospital, Lemminkäisenkatu 3/Teutori (3rd floor), 20014, Turku, Finland. ekjoki@utu.fi.
INVEST Research Flagship Center, University of Turku, Turku, Finland. ekjoki@utu.fi.

David Gyllenberg (D)

Department of Child Psychiatry, University of Turku and Turku University Hospital, Lemminkäisenkatu 3/Teutori (3rd floor), 20014, Turku, Finland.
Department of Adolescent Psychiatry, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
National Institute of Health and Welfare, Helsinki, Finland.
INVEST Research Flagship Center, University of Turku, Turku, Finland.

Dan Sucksdorff (D)

Department of Child Psychiatry, University of Turku and Turku University Hospital, Lemminkäisenkatu 3/Teutori (3rd floor), 20014, Turku, Finland.
INVEST Research Flagship Center, University of Turku, Turku, Finland.

Auli Suominen (A)

Department of Child Psychiatry, University of Turku and Turku University Hospital, Lemminkäisenkatu 3/Teutori (3rd floor), 20014, Turku, Finland.
INVEST Research Flagship Center, University of Turku, Turku, Finland.

Kim Kronström (K)

Department of Child Psychiatry, University of Turku and Turku University Hospital, Lemminkäisenkatu 3/Teutori (3rd floor), 20014, Turku, Finland.
Department of Adolescent Psychiatry, University of Turku and Turku University Hospital, Turku, Finland.
INVEST Research Flagship Center, University of Turku, Turku, Finland.

Roshan Chudal (R)

Department of Child Psychiatry, University of Turku and Turku University Hospital, Lemminkäisenkatu 3/Teutori (3rd floor), 20014, Turku, Finland.
INVEST Research Flagship Center, University of Turku, Turku, Finland.

Andre Sourander (A)

Department of Child Psychiatry, University of Turku and Turku University Hospital, Lemminkäisenkatu 3/Teutori (3rd floor), 20014, Turku, Finland.
INVEST Research Flagship Center, University of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH